Andrew Adams

Professor and Chief, Division of Transplantation


Administrative Assistant Contact: Stephanie Taylor | #612-625-5151 |

As a transplant surgeon and scientist, Dr. Adams is interested in developing the best therapies and diagnostics for transplant patients, by understanding the fundamental mechanisms of the immune system that give rise to organ rejection. As a graduate student, under the direction of Drs. Chris Larsen and Tom Pearson, Dr. Adams investigated the efficacy of costimulation blockade and helped develop Belatacept, now a clinically available therapy for transplant patients. Belatacept leads to improved survival and kidney function for renal transplant patients. The Adams' Lab has four main areas of investigation (1) costimulation blockade and costimulation independent rejection (2) xenotransplantation (3) transplant diagnostics (4) transplant outcomes.

Awards & Recognition

  • Doctor's Day Outstanding Faculty Recognition, Emory University School of Medicine, 2017 
  • Basic Science Career Development Award, American Society of Transplantation, 2017 
  • Fellow's Choice Award, Genzyme Transplant Fellows Conference, 2012
  • Woodruff Scholar Early Independence Award, 2011 
  • Chief Resident Teaching Award, General Surgery Residency Program, Massachusetts General Hospital, 2010 
  • Fellowship in Transplantation Award, American Society of Transplant Surgeons, 2010

Research Summary

Dr. Adams research efforts are concentrated on the development of novel strategies and therapeutics to promote transplantation tolerance. He has made important contributions to our understanding concerning the interplay between viral infection, immune memory and the allo-immune response. Dr. Adams is also an internationally recognized expert in large animal models of xenotransplantation (pig-to-non-human primateorgan transplant).

Research Interests
Liver Transplant
Kidney Transplant
Pediatric Transplant